The Microbiome is Associated with Responses to Neoadjuvant Therapy in Primary Nasopharyngeal Carcinoma

J. Chan,J. Chen,D. Yeung,Z. Chen
DOI: https://doi.org/10.1016/j.ijrobp.2024.01.173
IF: 8.013
2024-04-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Purpose/Objective(s) The microbiome has been noted to be altered in a variety of malignancies including nasopharyngeal carcinoma (NPC). Microbiome dysbiosis is postulated to affect the tumor immune microenvironment and potentially responses to radiotherapy, chemotherapy and immunotherapy. Here we sought to elucidate the role of the microbiome in predicting responses to neoadjuvant therapy. Materials/Methods Profiling of the human microbial communities in patients with primary nasopharyngeal carcinoma in stool, oral rinse and nasopharyngeal swab samples were collected simultaneously. Age and gender matched healthy control samples were also collected. Amplicon sequencing of the bacterial microbiome with 16S rRNA V3-V4 hypervariable region was done. A two-sided p value of <0.05 was considered statistically significant. A false discovery rate (FDR)-adjusted p value (q value) of <0.05 was used as the threshold for significance. Results We profiled the human microbial communities in patients with primary nasopharyngeal carcinoma (N=17), including 6 and 11 patients with complete or non-responder to neoadjuvant therapy respectively. Compared with their age- and gender-matched healthy controls (N=18), decreased alpha-diversity of oral rinse, stool and nasopharyngeal swab microbiota, as measured with Shannon index, Simpson index, evenness and richness, were observed in nasopharyngeal carcinoma patients (Figure 1A). We also observed distinct microbiota between communities from different anatomic sites, and also the shift between NPC patients and healthy controls (Figure 1B). At the genus level, interestingly, a significant increase in the relative abundance of Flavonifractor, Bilophila and Parabacteriodes in stools, and Halomonas in nasopharyngeal swabs was associated with non-responder to neoadjuvant therapy in NPC (p < 0.05) (Figure 1C). In addition, greater species level of Flavonifractor.plautii and Bilophila.wadsworthia in stool samples were found to be potentially associated with poor response to neoadjuvant therapy. Conclusion Overall, our data supports the association of dysbiosis of the human microbiota with primary nasopharyngeal carcinoma, and the change in the relative abundance of bacterial genus may play a role to the response to neoadjuvant therapy in NPC. Further studies are needed to evaluate the potential role of the microbiome in neoadjuvant therapy in NPC as a biomarker and treatment.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?